CCM
Consonance Capital Management Portfolio holdings
AUM
$7.28M
This Quarter Return
+3.44%
1 Year Return
-42.86%
3 Year Return
+319.33%
5 Year Return
+899.35%
10 Year Return
–
AUM
$938M
AUM Growth
+$938M
(-12%)
Cap. Flow
-$99.8M
Cap. Flow
% of AUM
-10.64%
Top 10 Holdings %
Top 10 Hldgs %
63.92%
Holding
49
New
11
Increased
10
Reduced
7
Closed
14
Top Buys
| 1 |
AFMD
Affimed
AFMD
|
$47.5M |
| 2 |
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
|
$42.6M |
| 3 |
Legend Biotech
LEGN
|
$26M |
| 4 |
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
|
$22.8M |
| 5 |
SWTX
SpringWorks Therapeutics
SWTX
|
$22.7M |
Top Sells
| 1 |
TCRR
TCR2 Therapeutics Inc. Common Stock
TCRR
|
$71.3M |
| 2 |
GNMK
GenMark Diagnostics, Inc
GNMK
|
$65.4M |
| 3 |
Mersana Therapeutics
MRSN
|
$37.3M |
| 4 |
KDMN
Kadmon Holdings, Inc.
KDMN
|
$30.5M |
| 5 |
Iovance Biotherapeutics
IOVA
|
$29.1M |
Sector Composition
| 1 | Healthcare | 96.03% |
| 2 | Financials | 0.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
United Therapeutics
UTHR
$13.8B
| $93.4M | 9.95% | 558,162 +29,198 | +6% | +$4.88M |
|
|
SWTX
2
DELISTED
SpringWorks Therapeutics
SWTX
| $88.4M | 9.42% | 1,201,399 +307,900 | +34% | +$22.7M |
|
3
MacroGenics
MGNX
$112M
| $78.7M | 8.39% | 2,472,447 +172,618 | +8% | +$5.5M |
|
4
Protagonist Therapeutics
PTGX
$3.67B
| $70.2M | 7.48% | 2,709,709 -20,000 | -0.7% | -$518K |
|
5
Keros Therapeutics
KROS
$618M
| $54.8M | 5.84% | 890,209 +333,114 | +60% | +$20.5M |
|
|
AFMD
6
DELISTED
Affimed
AFMD
| $47.5M | 5.07% | +6,008,974 | New | +$47.5M |
|
|
DCPH
7
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $44.6M | 4.75% | 993,912 +509,241 | +105% | +$22.8M |
|
|
MRTX
8
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $43.7M | 4.66% | 255,203 -74,797 | -23% | -$12.8M |
|
|
TPTX
9
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $42.6M | 4.54% | +450,396 | New | +$42.6M |
|
10
Globus Medical
GMED
$8.27B
| $35.7M | 3.8% | 578,371 -330,582 | -36% | -$20.4M |
|
11
Arvinas
ARVN
$568M
| $30.4M | 3.24% | 460,000 +35,000 | +8% | +$2.31M |
|
12
Verastem
VSTM
$569M
| $27.7M | 2.95% | 11,201,412 +3,421,226 | +44% | +$8.45M |
|
|
GMDA
13
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
| $26.8M | 2.86% | 3,318,207 +30,462 | +0.9% | +$246K |
|
|
14
Legend Biotech
LEGN
$6.41B
| $26M | 2.77% | +896,608 | New | +$26M |
|
15
CASI Pharmaceuticals
CASI
$35.8M
| $25.3M | 2.7% | 10,540,715 +2,964,284 | +39% | +$7.11M |
|
|
16
Iovance Biotherapeutics
IOVA
$807M
| $25M | 2.67% | 790,197 -920,606 | -54% | -$29.1M |
|
17
Atara Biotherapeutics
ATRA
$84.6M
| $24M | 2.56% | 1,669,293 -1,863,445 | -53% | -$26.8M |
|
18
Stereotaxis
STXS
$261M
| $23.6M | 2.51% | 3,508,676 +373,500 | +12% | +$2.51M |
|
|
INFI
19
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $21.2M | 2.26% | +6,575,000 | New | +$21.2M |
|
20
Nkarta
NKTX
$151M
| $18.8M | 2% | +570,255 | New | +$18.8M |
|
21
Adicet Bio
ACET
$59.9M
| $15.9M | 1.7% | +1,216,860 | New | +$15.9M |
|
|
CFMS
22
DELISTED
Conformis, Inc. Common Stock
CFMS
| $12.9M | 1.37% | +13,000,000 | New | +$12.9M |
|
|
CHFW.U
23
DELISTED
Consonance-HFW Acquisition Corp. Units, each consisting of one Class A Ordinary Share, and one-third
CHFW.U
| $9.76M | 1.04% | 1,000,000 | – | – |
|
|
SIOX
24
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $8.32M | 0.89% | 3,186,335 | – | – |
|
|
CTIC
25
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $7.31M | 0.78% | 2,512,800 | – | – |
|